Select Page

HEMOPHILIAAs a leading healthcare market research agency, AplusA has extensive experience researching diseases within hematology and hemato-oncology.

Hemophilia management is evolving as several new therapies for the treatment of both Hemophilia A and Hemophilia B are being launched or studied in clinical trials. Capitalizing on our unique expertise in patient chart-based research, the results from each wave of this study are based on real world data and monitor the impact of the new treatments for Hemophilia management. The latest wave of this study was conducted in 2020.

More information about HEMOPHILIAsyndiTrackTM our syndicated study? Fill in the form and we will be in touch shortly. 👉

You can also download our new Hemophilia A&B eBook:

Mockup Ebook AplusA Hemophilia 2020 EN

Download the eBook now